The University of Queensland

A Phase III Randomised Clinical Trial Comparing Patient Outcomes of Sentinel Lymph Node Dissection in Endometrial Cancer (ENDO-3PRO trial) (2020–2022)

Grant type:

Cherish Women's Cancer Foundation

Researchers:

• 

  Professor Andreas Obermair

  NHMRC Leadership Fellow
  

  UQ Centre for Clinical Research

  Faculty of Medicine

Funded by:

Cherish Women's Cancer Foundation